FindTrial
Sign In

Copeptin as a possible predictor of developing diabetes insipidus following transsphenoidal pituitary surgery

Copeptin as a possible predictor of developing diabetes insipidus following transsphenoidal pituitary surgery - Copeptin and diabetes insipidus

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41983
Enrollment
200
Registered
2015-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADH deficiency/or resistance

Interventions

None listed

Sponsors

Inwendige Geneeskunde/Endocrinologie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -adult patiënts scheduled for endoscopic transnasal pituitary surgery

Exclusion criteria

Exclusion criteria: - patients

Design outcomes

Primary

MeasureTime frame
The difference in copeptin levels between patients who develop DI and those who do not at several timepoints following surgery. We will also determine a cut-off level of copeptin which can be used to predict development of DI post surgery.—

Secondary

MeasureTime frame
-—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)